Plain-English translation of NCT06632379 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether atorvastatin, a medication that lowers cholesterol, can reduce your risk of future heart disease if you had high blood pressure during pregnancy. About 76 women will participate. Half will take the medication for 3 months after they finish breastfeeding, and half will take a placebo (a pill with no active ingredient), so researchers can see if the medication truly helps.
Women who develop high blood pressure or preeclampsia during pregnancy have a higher risk of heart disease later in life. Doctors want to know if starting this medication early in the postpartum period—when many women stop breastfeeding—might prevent serious heart problems down the road.
You likely qualify if…
You likely don't qualify if…
You will be followed for up to 1 year total. After you stop breastfeeding, you'll start taking either the medication or placebo once daily for 3 months. Researchers will measure your cholesterol, blood pressure, and heart disease risk using special scoring systems at the beginning, after 3 months, and again 3-6 months after you stop taking the pill. You'll also have blood work to check for any side effects.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States